{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:46:43Z","timestamp":1770886003332,"version":"3.50.1"},"reference-count":116,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ymgme.2020.07.011","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T19:09:37Z","timestamp":1596308977000},"page":"76-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Unraveling the mystery of Gaucher bone density pathophysiology"],"prefix":"10.1016","volume":"132","author":[{"given":"P.A.","family":"Rozenfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.N.","family":"Crivaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ormazabal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bondar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.V.","family":"Delpino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2020.07.011_bb0005","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0010","doi-asserted-by":"crossref","first-page":"192761","DOI":"10.1155\/2015\/192761","article-title":"Pathogenesis of bone alterations in Gaucher disease: The role of immune system","volume":"2015","author":"Mucci","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MD.0b013e3182057be4","article-title":"Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy","volume":"90","author":"Deegan","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0025","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s00223-019-00536-x","article-title":"A comprehensive study of bone manifestations in adult Gaucher disease type 1 patients in Argentina","volume":"104","author":"Oliveri","year":"2019","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0030","first-page":"273","article-title":"Gaucher disease in Latin America. A report from the Gaucher Disease International Registry and the Latin American Group for Gaucher Disease","volume":"72","author":"Drelichman","year":"2012","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040526","article-title":"Effect of substrate reduction therapy in comparison to enzyme replacement therapy on immune aspects and bone involvement in Gaucher disease","volume":"10","author":"Limgala","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bcmd.2017.06.003","article-title":"Skeletal involvement in type 1 Gaucher disease: Not just bone mineral density","volume":"68","author":"Baldini","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bone.2017.12.014","article-title":"Is fatty acid composition of human bone marrow significant to bone health?","volume":"118","author":"Pino","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0050","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1006\/bcmd.2001.0474","article-title":"Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease","volume":"27","author":"Hollak","year":"2001","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0055","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bcmd.2012.11.001","article-title":"Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease","volume":"50","author":"van Dussen","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0060","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1210\/jc.2011-0162","article-title":"Markers of bone turnover in Gaucher disease: modeling the evolution of bone disease","volume":"96","author":"van Dussen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1309\/AJCPFVSAEGO67NGT","article-title":"Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement","volume":"140","author":"Lebel","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.semnuclmed.2004.06.002","article-title":"Musculoskeletal system","volume":"34","author":"Jadvar","year":"2004","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0075","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1182\/blood-2004-06-2480","article-title":"Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche","volume":"105","author":"Taichman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0080","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1038\/sj.onc.1203245","article-title":"Mechanism and function of signal transduction by the Wnt\/beta-catenin and Wnt\/Ca2+ pathways","volume":"18","author":"Miller","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0085","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1128\/MCB.21.8.2891-2905.2001","article-title":"Runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins","volume":"21","author":"Javed","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0090","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1101\/gad.13.8.1025","article-title":"A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development","volume":"13","author":"Ducy","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0095","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbrc.2010.08.128","article-title":"Sclerostin is a direct target of osteoblast-specific transcription factor osterix","volume":"400","author":"Yang","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0100","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.1021\/ja070694c","article-title":"Self-organization of all-inorganic dodecatungstophosphate nanocrystallites","volume":"129","author":"Okamoto","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0105","first-page":"239","article-title":"Osteocytes: a proposed multifunctional bone cell","volume":"2","author":"Bonewald","year":"2002","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.bone.2012.09.040","article-title":"In vitro and in vivo approaches to study osteocyte biology","volume":"54","author":"Kalajzic","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00223-013-9774-y","article-title":"Osteocyte-driven bone remodeling","volume":"94","author":"Bellido","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186012","article-title":"Protective effect of low-dose risedronate against osteocyte apoptosis and bone loss in ovariectomized rats","volume":"12","author":"Ye","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0125","article-title":"Zoledronate enhances osteocyte-mediated osteoclast differentiation by IL-6\/RANKL axis","volume":"20","author":"Kim","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0130","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/jcb.21331","article-title":"Multiple roles of M-CSF in human osteoclastogenesis","volume":"102","author":"Hodge","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4248\/BR201301003","article-title":"Osteoclasts: new insights","volume":"1","author":"Feng","year":"2013","journal-title":"Bone Res"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0140","doi-asserted-by":"crossref","first-page":"26180","DOI":"10.1074\/jbc.M115.671271","article-title":"Combinatorial and computational approaches to identify interactions of macrophage colony-stimulating factor (M-CSF) and its receptor c-FMS","volume":"290","author":"Rosenfeld","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.abb.2014.05.003","article-title":"Osteoblast and osteocyte: games without frontiers","volume":"561","author":"Capulli","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/0470846658.ch16","article-title":"The molecular basis of osteoclast differentiation and activation","volume":"232","author":"Suda","year":"2001","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0155","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/BOR.0b013e3283025e9c","article-title":"Bone and fat connection in aging bone","volume":"20","author":"Duque","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0160","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jcb.240580312","article-title":"Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells","volume":"58","author":"Gimble","year":"1995","journal-title":"J. Cell. Biochem."},{"issue":"Pt 2","key":"10.1016\/j.ymgme.2020.07.011_bb0165","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1242\/jcs.102.2.341","article-title":"Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures","volume":"102","author":"Beresford","year":"1992","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcp.1041540215","article-title":"Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells","volume":"154","author":"Dorheim","year":"1993","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0175","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","article-title":"Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts","volume":"89","author":"Komori","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0180","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","article-title":"Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development","volume":"89","author":"Otto","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","article-title":"The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation","volume":"108","author":"Nakashima","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0190","doi-asserted-by":"crossref","first-page":"37731","DOI":"10.1074\/jbc.R100034200","article-title":"PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth","volume":"276","author":"Rosen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1073\/pnas.94.1.237","article-title":"Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor","volume":"94","author":"Tontonoz","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0200","doi-asserted-by":"crossref","first-page":"23270","DOI":"10.1074\/jbc.M211610200","article-title":"Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts","volume":"278","author":"Jeon","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-2143(03)00058-1","article-title":"Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts","volume":"142","author":"Khan","year":"2003","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0210","first-page":"151","article-title":"Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: potential implication in the treatment of age-related bone loss","volume":"19","author":"Ahdjoudj","year":"2004","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0215","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00018-008-8429-z","article-title":"Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program","volume":"66","author":"Muruganandan","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0220","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bone.2008.11.021","article-title":"Ebf1-dependent control of the osteoblast and adipocyte lineages","volume":"44","author":"Hesslein","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0225","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/1574888X10666150519093429","article-title":"PPARgamma and Wnt signaling in adipogenic and osteogenic differentiation of mesenchymal stem cells","volume":"11","author":"Yuan","year":"2016","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035712","article-title":"Resveratrol mediated modulation of Sirt-1\/Runx2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of Runx2 deacetylation","volume":"7","author":"Shakibaei","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0235","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/jbmr.460","article-title":"Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1\/FOXO3A axis","volume":"26","author":"Tseng","year":"2011","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0240","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1093\/nar\/gkq609","article-title":"SIRT1 is regulated by a PPAR{gamma}-SIRT1 negative feedback loop associated with senescence","volume":"38","author":"Han","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0245","doi-asserted-by":"crossref","first-page":"17643","DOI":"10.3390\/ijms140917643","article-title":"Oxidative stress and epigenetic regulation in ageing and age-related diseases","volume":"14","author":"Cencioni","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0250","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/jbmr.1824","article-title":"Silent information regulator (Sir)T1 inhibits NF-kappaB signaling to maintain normal skeletal remodeling","volume":"28","author":"Edwards","year":"2013","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0255","article-title":"Osteoimmunology Cold Spring Harb","volume":"9","author":"Okamoto","year":"2019","journal-title":"Perspect Med"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0260","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature11926","article-title":"CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance","volume":"495","author":"Greenbaum","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0265","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1084\/jem.20141843","article-title":"Specific bone cells produce DLL4 to generate thymus-seeding progenitors from bone marrow","volume":"212","author":"Yu","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0270","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.immuni.2016.05.012","article-title":"Sepsis-induced osteoblast ablation causes immunodeficiency","volume":"44","author":"Terashima","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0275","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nm.4251","article-title":"Dickkopf-1 promotes hematopoietic regeneration via direct and niche-mediated mechanisms","volume":"23","author":"Himburg","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0280","doi-asserted-by":"crossref","first-page":"9089610","DOI":"10.1155\/2016\/9089610","article-title":"The Alternative Faces of Macrophage Generate Osteoclasts","volume":"2016","author":"Lampiasi","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0285","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1084\/jem.178.5.1733","article-title":"Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts","volume":"178","author":"Fuller","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0290","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1172\/JCI116179","article-title":"Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors","volume":"91","author":"Tanaka","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0295","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bbrc.2009.09.026","article-title":"Direct effects of osteoprotegerin on human bone cell metabolism","volume":"389","author":"Grundt","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jb\/mvv112","article-title":"The role of osteoclast differentiation and function in skeletal homeostasis","volume":"159","author":"Ikeda","year":"2016","journal-title":"J Biochem"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0305","doi-asserted-by":"crossref","first-page":"720504","DOI":"10.1155\/2013\/720504","article-title":"The Interplay between the bone and the immune system","volume":"2013","author":"Mori","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0310","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.injury.2016.10.008","article-title":"The roles of immune cells in bone healing; what we know, do not know and future perspectives","volume":"47","author":"El-Jawhari","year":"2016","journal-title":"Injury"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0315","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar2936","article-title":"Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors","volume":"12","author":"Adamopoulos","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0320","first-page":"6","article-title":"The osteoprotegerin\/RANK\/RANKL system: a bone key to vascular disease","volume":"32","author":"D\u2019Amelio","year":"2009","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0325","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41232-019-0111-3","article-title":"RANKL biology: bone metabolism, the immune system, and beyond","volume":"40","author":"Ono","year":"2020","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0330","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1359\/jbmr.2001.16.12.2222","article-title":"Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice","volume":"16","author":"Visnjic","year":"2001","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0335","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/jbmr.1608","article-title":"Absence of sclerostin adversely affects B-cell survival","volume":"27","author":"Cain","year":"2012","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0340","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/357407a0","article-title":"Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene","volume":"357","author":"Tybulewicz","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0345","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0350","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.95.5.2503","article-title":"Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure","volume":"95","author":"Liu","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0355","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.4751","article-title":"Delineating pathological pathways in a chemically induced mouse model of Gaucher disease","volume":"239","author":"Vardi","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0360","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","article-title":"Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits","volume":"19","author":"Sun","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0365","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0370","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/hmg\/ddu538","article-title":"Glucocerebrosidase deficiency in zebrafish affects primary bone ossification through increased oxidative stress and reduced Wnt\/beta-catenin signaling","volume":"24","author":"Zancan","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069293","article-title":"A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patients","volume":"8","author":"Lecourt","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0380","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1182\/blood-2009-02-205708","article-title":"Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome","volume":"114","author":"Campeau","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0385","doi-asserted-by":"crossref","first-page":"18054","DOI":"10.1073\/pnas.1207889109","article-title":"Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease","volume":"109","author":"Panicker","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0390","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1242\/dmm.029009","article-title":"Induced pluripotent stem cell models of lysosomal storage disorders","volume":"10","author":"Borger","year":"2017","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0395","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1096\/fj.201901437R","article-title":"Glucosylceramide synthase regulates adipo-osteogenic differentiation through synergistic activation of PPARgamma with GlcCer","volume":"34","author":"Jang","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0400","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/scd.2011.0365","article-title":"Bone marrow microenvironment in an in vitro model of Gaucher disease: consequences of glucocerebrosidase deficiency","volume":"21","author":"Lecourt","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0405","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/hmg\/ddx442","article-title":"Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix deposition","volume":"27","author":"Panicker","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0410","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ymgme.2020.06.003","article-title":"Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis","volume":"130","author":"Crivaro","year":"2020","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0415","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/hmg\/ddz293","article-title":"A transcriptional and post-transcriptional dysregulation of Dishevelled 1 and 2 underlies the Wnt signaling impairment in type I Gaucher disease experimental models","volume":"29","author":"Costa","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0420","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1038\/s41598-017-03899-z","article-title":"Adiponectin regulates BMSC osteogenic differentiation and osteogenesis through the Wnt\/beta-catenin pathway","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0425","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.metabol.2006.10.014","article-title":"Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia","volume":"56","author":"Langeveld","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0430","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.molmed.2009.08.004","article-title":"Oxidative stress in bone remodelling and disease","volume":"15","author":"Wauquier","year":"2009","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","article-title":"Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage","volume":"62","author":"Cleeter","year":"2013","journal-title":"Neurochem Int"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0440","doi-asserted-by":"crossref","first-page":"514","DOI":"10.14336\/AD.2015.1206","article-title":"The role of bone marrow microenvironment in governing the balance between osteoblastogenesis and adipogenesis","volume":"7","author":"Li","year":"2016","journal-title":"Aging Dis"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0445","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbrc.2017.02.007","article-title":"NLRP3 inflammasome activation in mesenchymal stem cells inhibits osteogenic differentiation and enhances adipogenic differentiation","volume":"484","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0455","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1016\/j.biomaterials.2010.06.027","article-title":"Osteoclastogenesis in peripheral blood mononuclear cell cultures of periprosthetic osteolysis patients and the phenotype of T cells localized in periprosthetic tissues","volume":"31","author":"Roato","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0460","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/jcb.23352","article-title":"T cell-mediated increased osteoclast formation from peripheral blood as a mechanism for Crohn\u2019s disease-associated bone loss","volume":"113","author":"Oostlander","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0465","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1600-051X.2008.01241.x","article-title":"Formation of osteoclast-like cells from peripheral blood of periodontitis patients occurs without supplementation of macrophage colony-stimulating factor","volume":"35","author":"Tjoa","year":"2008","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0470","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gene.2012.07.071","article-title":"Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-alpha","volume":"509","author":"Mucci","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0475","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gene.2013.09.072","article-title":"Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease","volume":"532","author":"Mucci","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0480","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bone.2017.07.020","article-title":"In vitro osteoclastogenesis from Gaucher patients' cells correlates with bone mineral density but not with Chitotriosidase","volume":"103","author":"Bondar","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0485","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcmd.2015.05.009","article-title":"Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: Implication for bone pathology","volume":"55","author":"Mucci","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0490","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ymgme.2018.06.007","article-title":"Impact of sphingolipids on osteoblast and osteoclast activity in Gaucher disease","volume":"124","author":"Reed","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0495","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.gene.2018.08.045","article-title":"Generation of osteoclasts from type 1 Gaucher patients and correlation with clinical and genetic features of disease","volume":"678","author":"Reed","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0500","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jbmr.3734","article-title":"Gaucher Disease in Bone: From Pathophysiology to Practice","volume":"34","author":"Hughes","year":"2019","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0505","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymgme.2017.08.005","article-title":"Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naive and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials","volume":"122","author":"Elstein","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0510","first-page":"165","article-title":"Gaucher disease: the role of the specialist on metabolic bone diseases","volume":"12","author":"Masi","year":"2015","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0515","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.clinthera.2007.08.006","article-title":"Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies","volume":"29","author":"Pastores","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0520","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejim.2016.07.011","article-title":"Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe","volume":"37","author":"Belmatoug","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0525","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1750-1172-7-102","article-title":"Evaluation of miglustat as maintenance therapy after enzyme therapy in adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority study","volume":"7","author":"Cox","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0530","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bcmd.2013.04.005","article-title":"Miglustat therapy in type 1 Gaucher disease: clinical and safety outcomes in a multicenter retrospective cohort study","volume":"51","author":"Kuter","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0535","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrd.2017.214","article-title":"Emptying the stores: lysosomal diseases and therapeutic strategies","volume":"17","author":"Platt","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0540","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcmd.2012.09.006","article-title":"Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease","volume":"50","author":"Zimran","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0545","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ejp.1538","article-title":"Dual-action ambroxol in treatment of chronic pain in Gaucher Disease","volume":"24","author":"Pawlinski","year":"2020","journal-title":"Eur J Pain"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0550","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s10038-019-0704-3","article-title":"Ambroxol improves skeletal and hematological manifestations on a child with Gaucher disease","volume":"65","author":"Jiang","year":"2020","journal-title":"J Hum Genet"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0555","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bcmd.2016.10.004","article-title":"The utility of magnetic resonance imaging for bone involvement in Gaucher disease. Assessing more than bone crises","volume":"68","author":"Andrade-Campos","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2020.07.011_bb0560","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jbspin.2010.02.045","article-title":"Bone involvement as presenting sign of pediatric-onset Gaucher disease","volume":"78","author":"Rossi","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0565","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s12325-014-0174-0","article-title":"Management of bone disease in Gaucher disease type 1: clinical practice","volume":"31","author":"Giuffrida","year":"2014","journal-title":"Adv Ther"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0570","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood-2003-11-3854","article-title":"Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy","volume":"104","author":"Wenstrup","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0575","first-page":"23","article-title":"Improvement in bone mineral density and architecture in a patient with Gaucher disease using teriparatide","volume":"22","author":"Khan","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0580","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-019-0608-z","article-title":"Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension","volume":"14","author":"Miyauchi","year":"2019","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.ymgme.2020.07.011_bb0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217780","article-title":"Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease","volume":"14","author":"Crivaro","year":"2019","journal-title":"PLoS One"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220301803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220301803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:29:23Z","timestamp":1761089363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719220301803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1096719220301803"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.07.011","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the mystery of Gaucher bone density pathophysiology","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}